Caner Saygin

Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients

Caner Saygin, Joseph Cannova, Wendy Stock et al. · Haematologica · 2022 · 69 citations · Full text

Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes

Caner Saygin, Ashwin Kishtagari, Ryan D. Cassaday et al. · Blood Advances · 2019 · 54 citations · Full text

Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1

Caner Saygin, Cassandra M. Hirsch, Bartlomiej Przychodzen et al. · Blood Cancer Journal · 2018 · 53 citations · Full text

Poor Outcome, Mixed-phenotype Acute Leukemia, Pathology +19

Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival

Ferhat Özden, Caner Saygin, Didem Uzunaslan et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 50 citations · Full text

Urology, Oncology, Prostate Carcinoma +8

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

Caner Saygin, Gregory W. Roloff, Christopher N Hahn et al. · Blood Advances · 2022 · 45 citations · Full text

Mixed-phenotype Acute Leukemia, Genetic Epidemiology, Immunology +20